-
US must not be 'too honest' at World Cup, says Roldan
-
Italian astronaut to pilot Artemis III mission
-
North Korea says Xi's visit produced 'far-reaching blueprint' for ties
-
Benfica say farewell to Mourinho as Real Madrid return nears
-
Protesters torch buildings and vehicles, block roads over Belfast stabbing
-
US strikes Iran after Apache helicopter downing
-
Threats to US lawmakers spiked after Meta eased moderation: watchdog
-
Nick Reiner seeks trust fund money for parent murder defense
-
Spain, France qualify for 2027 Women's World Cup as England wait
-
Protesters torch building and vehicles, block roads over Belfast stabbing
-
A woman in charge of the UN? Candidates feel it's about time
-
US tech shares resume sell-off while oil prices retreat
-
Protesters block road to Mexican World Cup stadium
-
White House World Cup chief defends visa ban for Somali referee, Iranians
-
Serena back in the groove on triumphant return to tennis
-
'It doesn't matter': US star Reyna looks past World Cup scandal
-
Somali referee says World Cup 'dream' ruined
-
Knicks ready to 'throw the first punch' in NBA Finals
-
'Beaten to death': the grim toll of Ecuador's security crackdown
-
Anthropic opens most powerful AI model to public with safeguards
-
Serena Williams makes winning return in Queen's Club doubles
-
Trump vows response after Iran shoots down US helicopter
-
Real Madrid's 150 mn euros bid for Atletico's Alvarez rejected
-
Spurs handling physicality of Knicks and New York hostility
-
Peru election chief tells AFP count could take two weeks
-
Stokes considering England captaincy future after nightclub incident
-
Atalanta sack coach Palladino with Sarri set to arrive
-
Italian Luca Parmitano to be first European to join an Artemis mission: NASA
-
One killed as Kenyan protests at US Ebola centre turn violent
-
Somali government deeply regrets axing of referee from World Cup
-
Scotland First Minister vows to help fans refused entry for World Cup in US
-
Stocks slump as US tech rebound falters, oil dips below $90
-
Somalia backs referee after he is denied entry to US
-
Lord's pitch rated 'unsatisfactory' by ICC
-
Pope Leo XIV met Bad Bunny in Madrid on Monday: Vatican
-
Stocks turn lower as US tech rebound falters
-
EU orders Meta to open WhatsApp to rival AI chatbots for free
-
Visma win Auvergne team time-trial but Baudin keeps yellow
-
Nintendo to remake classic 'Zelda' game 'Ocarina of Time'
-
Bangladesh thrash Australia in rain-hit first ODI
-
Woolly mammoth among trove of ancient DNA found in squirrel poo
-
Appeals for calm after 'sickening' Belfast stabbing spurs protest calls
-
Afghan police disperse women's rights rally in Herat
-
Six Georgians tried in France over theft of rare Russian books
-
US trade gap narrows in April on oil exports boost
-
Stocks rise, oil eases after Trump evokes Iran deal
-
One shot as Kenyan protests at US Ebola centre turn violent
-
Townsend says Dempsey still part of Scotland set-up despite Japan move
-
Trump-linked resort plan ignites Albanian discontent
-
Itoje out of latest England training squad
Japanese researchers test pioneering drug to regrow teeth
People with missing teeth may be able to grow new ones, say Japanese dentists testing a pioneering drug they hope will offer an alternative to dentures and implants.
Unlike reptiles and fish, which usually replace their fangs on a regular basis, it is widely accepted that humans and most other mammals only grow two sets of teeth.
But hidden underneath our gums are the dormant buds of a third generation, according to Katsu Takahashi, head of oral surgery at the Medical Research Institute Kitano Hospital in Osaka.
His team launched clinical trials at Kyoto University Hospital in October, administering an experimental medicine to adult test subjects that they say has the potential to jumpstart the growth of these concealed teeth.
It's a technology "completely new" to the world, Takahashi told AFP.
Prosthetic treatments used for teeth lost to decay, disease or injury are often seen as costly and invasive.
So "restoring natural teeth definitely has its advantages", said Takahashi, the project's lead researcher.
Tests on mice and ferrets suggest that blocking a protein called USAG-1 can awaken the third set, and the researchers have published lab photographs of regrown animal teeth.
In a study published last year, the team said their "antibody treatment in mice is effective for tooth regeneration and can be a breakthrough in treating tooth anomalies in humans".
- 'Only the beginning' -
For now, the dentists are prioritising the "dire" needs of patients with six or more permanent teeth missing from birth.
The hereditary condition is said to affect around 0.1 percent of people, who can have severe trouble chewing, and in Japan often spend most of their adolescence wearing a face mask to hide the wide gaps in their mouth, Takahashi said.
"This drug could be a game-changer for them," he added.
The drug is therefore aimed primarily at children, and the researchers want to make it available as early as 2030.
Angray Kang, a dentistry professor at Queen Mary University of London, only knows of one other team pursuing a similar objective of using antibodies to regrow or repair teeth.
"I would say that the Takahashi group is leading the way," the immunotechnology expert, who is not connected to the Japanese research, told AFP.
Takahashi's work is "exciting and worth pursuing", Kang said, in part because an antibody drug that targets a protein nearly identical to USAG-1 is already being used to treat osteoporosis.
"The race to regenerate human teeth is not a short sprint, but by analogy a set of back-to-back consecutive ultra-marathons," he said.
"This is only the beginning."
Chengfei Zhang, a clinical professor in endodontics at the University of Hong Kong, said Takahashi's method is "innovative and holds potential".
"The assertion that humans possess latent tooth buds capable of producing a third set of teeth is both revolutionary and controversial," he told AFP.
He also cautioned that "outcomes observed in animals do not always directly translate to humans".
The results of the animal experiments raise "questions about whether regenerated teeth could functionally and aesthetically replace missing teeth", Zhang added.
- 'Over the moon' -
A confident Takahashi argues that the location of a new tooth in a mouth can be controlled, if not pinpointed, by the drug injection site.
And if it grows in the wrong place, it can be moved through orthodontics or transplantation, he said.
No young patients with the congenital disorder are taking part in the first clinical trial, as the main objective is to test the drug's safety, rather than its effectiveness.
So for now, the participants are healthy adults who have lost at least one existing tooth.
And while tooth regeneration is not the express goal of the trial this time around, there is a slim chance that it could happen to subjects anyway, Takahashi said.
If so, the researchers will have confirmed that the drug can be effective for those with acquired toothlessness -- which would be a medical triumph.
"I would be over the moon if that happens," Takahashi said.
This could be particularly welcome news in Japan, which has the second-oldest population in the world.
Health ministry data shows more than 90 percent of people aged 75 or older in Japan have at least one tooth missing.
"Expectations are high that our technology can directly extend their healthy life expectancy," Takahashi said.
S.AbuJamous--SF-PST